title: Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
abstract: Cervical cancer is the second most common cancer in women worldwide, and the most common cause of death from cancer in women in the developing world. Cervical cancer represents the only gynecologic cancer that can be prevented through regular screening. Although there are established screening programs in the Western world that have effectively reduced the burden of cervical cancer, these programs have relied on insensitive screening technologies that depend on the long preinvasive phase of cervical carcinogenesis. The developing world faces specific additional challenges in implementing a successful cervical cancer screening program. The association between cervical cancers and human papillomavirus (HPV) make testing for the presence of HPV DNA a valuable screening tool. This review focuses on practical aspects of the implementation and delivery of HPV testing as the primary cervical cancer screening strategy in the developing world, and attempts to offer some solutions to the real-world challenges faced in these regions.
authors.affiliation: Preventive Oncology International, Inc., Cleveland Heights, Ohio 44118, USA. seb@poiinc.org
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Belinson
authors.forename: Jerome L
authors.initials: JL
authors.lastname: Belinson
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000453:epidemiology / Q000821:virology; D002584:Cervix Uteri / Q000821:virology; D004279:DNA, Viral / Q000302:isolation & purification*; D003906:Developing Countries; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000821:virology; D014626:Vaginal Smears
chemical_list: D004279:DNA, Viral
references.citation: Cancer. 1998 Nov 15;83(10):2150-6
references.pmid: 9827719
references.citation: Int J Gynecol Cancer. 2009 Jan;19(1):27-32
references.pmid: 19258937
references.citation: J Obstet Gynaecol. 2001 Nov;21(6):617-21
references.pmid: 12521783
references.citation: J Clin Microbiol. 2006 Apr;44(4):1310-7
references.pmid: 16597856
references.citation: Cochrane Database Syst Rev. 2010 Jun 16;(6):CD001318
references.pmid: 20556751
references.citation: Int J Cancer. 2010 Sep 1;127(5):1151-7
references.pmid: 20039323
references.citation: Obstet Gynecol. 1998 Nov;92(5):737-44
references.pmid: 9794661
references.citation: J Clin Virol. 2009 Jul;45 Suppl 1:S63-72
references.pmid: 19651371
references.citation: N Engl J Med. 2007 Oct 18;357(16):1579-88
references.pmid: 17942871
references.citation: Gynecol Oncol. 2001 Nov;83(2):439-44
references.pmid: 11606114
references.citation: Int J Cancer. 2006 Sep 1;119(5):1095-101
references.pmid: 16586444
references.citation: Clin Chem. 2008 Jan;54(1):86-92
references.pmid: 17981923
references.citation: Am J Epidemiol. 2009 Sep 15;170(6):708-16
references.pmid: 19692327
references.citation: Int J Cancer. 2008 May 15;122(10):2294-300
references.pmid: 18240149
references.citation: N Engl J Med. 2009 Apr 2;360(14):1385-94
references.pmid: 19339719
references.citation: Int J Cancer. 2006 Dec 1;119(11):2677-84
references.pmid: 16991121
references.citation: Lancet. 1987 May 30;1(8544):1247-9
references.pmid: 2884378
references.citation: N Engl J Med. 2007 Oct 18;357(16):1589-97
references.pmid: 17942872
references.citation: JAMA. 2003 Aug 13;290(6):781-9
references.pmid: 12915431
references.citation: Int J Gynecol Cancer. 2010 Apr;20(3):422-7
references.pmid: 20375808
references.citation: BMJ. 2008 Oct 13;337:a1754
references.pmid: 18852164
references.citation: Lancet. 2007 Aug 4;370(9585):398-406
references.pmid: 17679017
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Lancet Oncol. 2008 Oct;9(10):929-36
references.pmid: 18805733
references.citation: BMC Womens Health. 2010 Apr 01;10:11
references.pmid: 20359354
references.citation: J Clin Virol. 2009 Jul;45 Suppl 1:S93-7
references.pmid: 19651375
references.citation: Int J Gynecol Cancer. 2003 Nov-Dec;13(6):819-26
references.pmid: 14675319
references.citation: Br J Cancer. 2003 Jul 7;89(1):101-5
references.pmid: 12838308
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1157-64
references.pmid: 15894666
references.citation: J Low Genit Tract Dis. 2003 Apr;7(2):107-16
references.pmid: 17051055
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: Br J Cancer. 2003 Jan 13;88(1):63-73
references.pmid: 12556961